The expanded library of novel and patentable synthetic promoters is designed to improve protein production in CHO (Chinese Hamster Ovary) cells. Developed de novo using the Company's proprietary transcriptional analysis and sequence engineering platform, CHO.SET synthetic promoters combine advanced computational design with empirical validation to deliver a highly diverse promoter library applicable across a wide range of CHO expression systems and biomanufacturing requirements. Dr Andrew Racher, Co-CEO, SynGenSys, commented: "CHO cells are the pharmaceutical industry's gold-standard cell factories, and CHO cell-specific synthetic promoters provide an elegant solution to overcoming key productivity limitations in the industry.